Background The oligometastatic paradigm suggests that some patients with a limited number
of metastases might be cured if all lesions are eradicated. Evidence from randomised …

PURPOSE The oligometastatic paradigm hypothesizes that patients with a limited number of
metastases may achieve long-term disease control, or even cure, if all sites of disease can …

BACKGROUND: This study was undertaken to determine outcomes of stereotactic body
radiotherapy for colorectal liver metastases in a pooled patient cohort. METHODS: Patients with …

Over the past decade, there has been an increasing use of radiotherapy (RT) for the treatment
of liver metastases. Most often, ablative doses are delivered to focal liver metastases with …

Purpose Long-term randomized data assessing the effect of ablative therapies in patients
with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the …

Background Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment
option for patients with oligometastatic disease. SABR delivers precise, high-dose, …

BACKGROUND Stereotactic ablative radiotherapy (SABR) is an emerging therapy for
primary renal cell carcinoma. The authors assessed safety, efficacy, and survival in a multi‐…

Background Stereotactic ablative body radiotherapy (SABR) is a non-invasive treatment option
for primary renal cell carcinoma, for which long-term data are awaited. The primary aim of …

Importance Unresected locally advanced non–small cell lung cancer (LA-NSCLC) shows
poor survival outcomes even after aggressive concurrent chemoradiotherapy. Whether …

Background Despite the paucity of prospective evidence, stereotactic radiotherapy (SRT) is
increasingly being considered in the setting of oligoprogression to delay the need to change …